OverviewChartNewsTraderScreen

DZ Bank Knock-Out QIA/  DE000DF9Y3S6  /

Frankfurt Zert./DZB
21/06/2024  11:34:59 Chg.-0.010 Bid11:40:44 Ask- Underlying Strike price Expiration date Option type
0.520EUR -1.89% 0.520
Bid Size: 55,000		 -
Ask Size: -		 QIAGEN NV 33.6048 EUR 31/12/2078 Call
GlobeNewswire 17/06 QIAGEN announces 2028 strategy for solid profitable growth
GlobeNewswire 13/06 QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput N...
GlobeNewswire 12/06 QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to su...
GlobeNewswire 11/06 QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious dis...
GlobeNewswire 06/06 QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition per...
GlobeNewswire 05/06 QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of it...
GlobeNewswire 03/06 QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improv...
GlobeNewswire 30/05 QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire 30/05 QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire 29/05 QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision ...
GlobeNewswire 22/05 deepull appoints Didier Deltort to its Board of Directors
GlobeNewswire 14/05 QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical devic...
GlobeNewswire 13/05 QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accura...
GlobeNewswire 07/05 QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
GlobeNewswire 07/05 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 07/05 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 02/05 QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inher...
GlobeNewswire 29/04 QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
GlobeNewswire 25/04 deepull unveils 1 hour, direct-from-blood multiplex PCR test for 95% of sepsis-causing pathogens at ...
GlobeNewswire 24/04 QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and comba...
GlobeNewswire 18/04 deepull appoints Kimberle Chapin, MD, as Chief Medical Officer and Wade Stevenson as Chief Marketing...
GlobeNewswire 09/04 QIAGEN N.V. to release results for Q1 2024 and hold webcast
GlobeNewswire 03/04 QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Ann...
GlobeNewswire 25/03 QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration a...
GlobeNewswire 18/03 QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosi...